Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. Mucoactive agent - Wikipedia
Mucoactive agent - Wikipedia
From Wikipedia, the free encyclopedia
(Redirected from Expectorant)
Drugs that clear mucus from airways

Cough medicines usually contain mucoactive agents

Mucoactive agents are a class of pharmacologic agents that include expectorants, mucolytics, mucoregulators, and mucokinetics that can affect the volume, viscosity, transportation, and composition of mucus or sputum.[1][2][3] They often aid in clearing mucus or sputum from the upper and lower airways. These medications are used to treat respiratory diseases complicated by the oversecretion or inspissation of mucus. These drugs can be further categorized by their mechanism of action.[4][5]

Mechanism of action

[edit]

Mucoactive agents—expectorants—include mucolytics, secretolytics and mucokinetics (also called secretomotorics) [6]

  • Mucolytics: thin (reduce the viscosity of) mucus[5]
  • Secretolytics: increase airway water or the volume of airway secretions [5]
  • Mucokinetics: increase mucociliary transport (clearance) and transportability of mucus by cough [5]
  • Mucoregulators: suppress underlying mechanisms of mucus hypersecretion[5]

Alternatively, attacking the affinity between secretions and the biological surfaces is another avenue, which is used by abhesives and surfactants.[citation needed]

Any of these effects could improve airway clearance during coughing.[citation needed]

In general, clearance ability is hampered by the bonding to surfaces (stickiness) and by the viscosity of mucous secretions in the lungs. In turn, the viscosity is dependent upon the concentration of mucoprotein in the secretions.

Mucolytics, secretolytics and secretomotorics are different types of medication, yet they are intended to promote drainage of mucus from the lungs.

An expectorant (from the Latin expectorare, to expel or banish) works by signaling the body to increase the amount or hydration of secretions, resulting in more, yet clearer, secretions and lubricating the irritated respiratory tract.[7] One mucoactive agent, guaifenesin, has anxiolytic and muscle-relaxing properties. It is commonly available in cough syrups and also as sustained-release tablets.

Mucolytics can dissolve thick mucus and are usually used to help relieve respiratory difficulties. They do this by breaking down the chemical bonds between molecules in the mucus.[8] This in turn can lower the viscosity by altering the mucin-containing components.[citation needed]

An expectorant increases bronchial secretions and mucolytics help loosen thick bronchial secretions. Expectorants reduce the thickness or viscosity of bronchial secretions, thus increasing mucus flow that can be removed more easily through coughing. Mucolytics break down the chemical structure of mucus molecules. The mucus becomes thinner and can be removed more easily through coughing.

— Adams, Holland, & Bostwick, 2008, p. 591

Mucoactive drugs

[edit]
  • Thiols
    • acetylcysteine
    • mesna
  • Thioesters
    • carbocisteine
    • erdosteine
    • mecysteine
  • Bromhexine-like
    • ambroxol
    • bromhexine
  • DNAse
    • dornase alpha
  • Irritative secretolytics
    • ammonium chloride (not believed to work by the FDA)[9]
  • Citrates
    • potassium citrate
    • sodium citrate (not believed to work by the FDA)[9]
  • Iodides
    • Potassium iodide
  • Plant-derived compounds or extracts
    • guaifenesin (does not work in upper respiratory tract infections)[10][11]
    • terpin hydrate (not believed to work by the FDA)[9]
    • tolu balsam (not believed to work by the FDA)[9]
    • Justicia adhatoda extracts

References

[edit]
  1. ^ Hocquigny, Alexis; Hugerot, Hélène; Ghanem, Rosy; Haute, Tanguy; Laurent, Véronique; Cogulet, Virginie; Montier, Tristan (2024). "Mucoactive drugs and multiple applications in pulmonary disease therapy". European Journal of Pharmaceutics and Biopharmaceutics. 194: 110–117. doi:10.1016/j.ejpb.2023.12.001. ISSN 1873-3441. PMID 38048888. These drugs are classified based on their mechanism of action and mucus integration [14]. They are grouped into four different classes: expectorants, mucokinetics, mucoregulators or mucolytics.
  2. ^ Dorow, P. (1990). "Mucolytics: When dispensable, when necessary?". Lung. 168 (S1): 622–626. doi:10.1007/BF02718186. ISSN 0341-2040. PMID 2117172. Retrieved 12 June 2025. Mucolytic drugs can alter the rheological properties of mucus by acting directly on the secretions or by modifying the metabolic activity of the mucus secreting cells. ... four different classes: promotion of mucus transportation, reflex augmentation of secretion, change of physical/chemical.
  3. ^ Gupta, Rishab; Wadhwa, Roopma (2025). "Mucolytic Medications". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32644589. Retrieved 12 June 2025. Mucolytics are drugs belonging to the class of mucoactive agents.
  4. ^ Balsamo, R.; Lanata, L.; and Egan, C. G. (2010). "Mucoactive drugs". European Respiratory Review. 19 (116): 127–33. doi:10.1183/09059180.00003510. PMC 9682576. PMID 20956181.
  5. ^ a b c d e Rogers, D. F. (2007). "Mucoactive agents for airway mucus hypersecretory diseases". Respiratory Care. 52 (9): 1176–93, discussion 1193–7. PMID 17716385.
  6. ^ Rubin, Bruce K. (2006). "The pharmacologic approach to airway clearance: Mucoactive agents". Paediatric Respiratory Reviews. 7 (Supplement 1): S215–S219. doi:10.1016/j.prrv.2006.04.198. PMID 16798570.
  7. ^ "Definition of Expectorant". MedicineNet. 13 May 2016. Archived from the original on 11 August 2020. Retrieved 4 January 2018.
  8. ^ "NCATS Inxight: Drugs – MECYSTEINE HYDROCHLORIDE". drugs.ncats.io. Archived from the original on 29 May 2019. Retrieved 29 May 2019.
  9. ^ a b c d United States Food and Drug Administration: Code of Federal Regulations, Title 21, Volume 5, April 1, 2009
  10. ^ Hoffer-Schaefer A, Rozycki HJ, Yopp MA, Rubin BK (May 2014). "Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections". Respiratory Care. 59 (5): 631–636. doi:10.4187/respcare.02640. PMID 24003241.
  11. ^ O'Connell OJ (May 2014). "Is extended-release guaifenesin no better than a placebo?". Respir Care. 59 (5): 788–9. doi:10.4187/respcare.03319. PMID 24789023.
  • Adams, Michael; Holland, Leland Norman; Bostwick, Paula Manuel (2016). Pharmacology for Nurses: A Pathophysiologic Approach (5 ed.). Pearson Education. p. 960. ISBN 978-0134255163.
  • Rubin, Bruce K (1 July 2007). "Mucolytics, Expectorants, and Mucokinetic Medications". Respiratory Care. 52 (7): 859–865. PMID 17594730.

External links

[edit]
  • National Center for Biotechnology Information[dead link]
  • v
  • t
  • e
Cough and cold preparations (R05)
Expectorants
  • Althea root
  • Ammonium chloride
  • Antimony pentasulfide
  • Cineole
  • Creosote
  • Guaiacolsulfonate
  • Guaifenesin (+codeine, +hydrocodone, +oxomemazine)
  • Hederae helicis folium
  • Ipecacuanha (Syrup of ipecac)
  • Levoverbenone
  • Potassium iodide
  • Senega
  • Tyloxapol
Mucolytics
  • Acetylcysteine#
  • Ambroxol
  • Bromhexine
  • Carbocisteine
  • Dembrexine hydrochloride
  • Domiodol
  • Dornase alfa
  • Eprazinone
  • Erdosteine
  • Letosteine
  • Mannitol
  • Mesna
  • Neltenexine
  • Sobrerol
  • Stepronin
Cough suppressants
Opium alkaloids,
opioids,
and derivatives
  • Acetyldihydrocodeine
  • Benzylmorphine
  • Butorphanol
  • Codeine# (+guaifenesin)
  • Dextromethorphan
  • Dihydrocodeine
  • Dimemorfan
  • Ethylmorphine
  • Heroin
  • Hydrocodone (+guaifenesin, +homatropine)
  • Hydromorphone
  • Laudanum
  • Levomethadone
  • Levopropoxyphene
  • Methadone
  • Nicocodeine
  • Nicodicodeine
  • Normethadone
  • Noscapine
  • Pholcodine
  • Thebacon
Other
  • Alloclamide
  • Benproperine
  • Benzonatate
  • Bibenzonium bromide
  • Butamirate
  • Clobutinol
  • Clofedanol
  • Cloperastine
  • Dibunate
  • Dimethoxanate
  • Diphenhydramine
  • Dropropizine
  • Droxypropine
  • Fedrilate
  • Fominoben
  • Gefapixant
  • Glaucine
  • Isoaminile
  • Levodropropizine
  • Meprotixol
  • Moguisteine
  • Morclofone
  • Nepinalone
  • Oxeladin
  • Oxolamine
  • Pentoxyverine
  • Pipazetate
  • Piperidione
  • Prenoxdiazine
  • Tipepidine
  • Zipeprol
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III
Portal:
  • icon Medicine
Retrieved from "https://teknopedia.ac.id/w/index.php?title=Mucoactive_agent&oldid=1310096858"
Categories:
  • Pulmonology
  • Expectorants
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata
  • Use dmy dates from May 2021
  • All articles with unsourced statements
  • Articles with unsourced statements from May 2019
  • All articles with dead external links
  • Articles with dead external links from July 2025

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id